Progression of myeloproliferative neoplasm with BCR::JAK2 fusion to acute leukemia of ambiguous lineage

被引：0
|
作者：
Edwin Uriel Suárez
Miguel Ángel Piris
Socorro María Rodríguez-Pinilla
Juan F. García
José Luis López-Lorenzo
Javier Cornago-Navascués
Rocío Salgado-Sánchez
Tamara Castaño-Bonilla
Raquel Mata-Serna
Juan M. Alonso-Domínguez
Pilar Llamas
机构：
[1] Health Research Institute-Fundación Jiménez Díaz University Hospital,Department of Hematology
[2] Universidad Autónoma de Madrid,Department of Pathology
[3] Health Research Institute-Fundación Jiménez Díaz University Hospital,Department of Pathology
[4] Universidad Autónoma de Madrid,undefined
[5] MD Anderson Cancer Center,undefined
来源：
Annals of Hematology | 2024年 / 103卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1797 / 1799
页数：2
相关论文
共 50 条
  • [31] Molecular and clinical features of the myeloproliferative neoplasm associated with JAK2 exon 12 mutations
    Passamonti, Francesco
    Elena, Chiara
    Schnittger, Susanne
    Skoda, Radek C.
    Green, Anthony R.
    Girodon, Francois
    Kiladjian, Jean-Jacques
    McMullin, Mary Frances
    Ruggeri, Marco
    Besses, Carles
    Vannucchi, Alessandro M.
    Lippert, Eric
    Gisslinger, Heinz
    Rumi, Elisa
    Lehmann, Thomas
    Ortmann, Christina A.
    Pietra, Daniela
    Pascutto, Cristiana
    Haferlach, Torsten
    Cazzola, Mario
    BLOOD, 2011, 117 (10) : 2813 - 2816
  • [32] Quantitative Proteome Heterogeneity in Myeloproliferative Neoplasm Subtypes and Association with JAK2 Mutation Status
    Socoro-Yuste, Nuria
    Cokic, Vladan P.
    Mondet, Julie
    Plo, Isabelle
    Mossuz, Pascal
    MOLECULAR CANCER RESEARCH, 2017, 15 (07) : 852 - 861
  • [33] Acceleration of Bcr-Abl+ leukemia induced by deletion of JAK2
    Grundschober, E.
    Hoelbl-Kovacic, A.
    Bhagwat, N.
    Kovacic, B.
    Scheicher, R.
    Eckelhart, E.
    Kollmann, K.
    Keller, M.
    Grebien, F.
    Wagner, K-U
    Levine, R. L.
    Sexl, V.
    LEUKEMIA, 2014, 28 (09) : 1918 - 1922
  • [34] JAK2 mutations in myeloproliferative disorders
    Tefferi, A
    Lasho, TL
    Gilliland, G
    NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (13): : 1416 - 1417
  • [35] A Patient With BCR-ABL and JAK2 V617F Double-Positive Myeloproliferative Neoplasm With Overlapping Clinical Phenotypes
    Wang, Yadan
    Xia, Jia
    Wu, Xiaofei
    Hu, Yu
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2015, 350 (01): : 68 - 69
  • [36] Concomitant detection of BCR-ABL translocation and JAK2 V617F mutation in five patients with myeloproliferative neoplasm at diagnosis
    Cappetta, M.
    Perez, V.
    Zubillaga, M. N.
    Elizondo, V.
    Manrique, G.
    Prosper, I.
    Boschi, S.
    Bonomi, R.
    Pomoli, S.
    Diaz, L.
    Martinez, L.
    Uriarte, M. R.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2013, 35 (01) : E4 - E5
  • [37] RUXOLITINIB AS POTENTIAL TARGETED THERAPY FOR MYELOPROLIFERATIVE NEOPLASMS WITH JAK2 FUSION PROTEINS
    Chase, A.
    Bryant, C.
    Score, J.
    Haferlach, C.
    Schwaab, J.
    Hofmann, W. K.
    Reiter, A.
    Cross, N.
    HAEMATOLOGICA, 2012, 97 : 436 - 436
  • [38] TLE3 Is a Novel Fusion Partner of JAK2 in Myeloid/Lymphoid Neoplasm With Eosinophilia Responding to JAK2 Inhibition
    Lazarevic, Vladimir
    Lilljebjorn, Henrik
    Olsson-Arvidsson, Linda
    Orsmark-Pietras, Christina
    Agerstam, Helena
    GENES CHROMOSOMES & CANCER, 2024, 63 (08):
  • [39] PCM1::JAK2 myeloproliferative neoplasm suggested by bone marrow histopathological features
    Loscocco, Giuseppe G.
    Santi, Raffaella
    BLOOD, 2024, 143 (23) : 2439 - 2439
  • [40] JAK2/IDH-mutant-driven myeloproliferative neoplasm is sensitive to combined targeted inhibition
    McKenney, Anna Sophia
    N., Allison
    Somasundara, Amritha Varshini Hanasoge
    Spitzer, Barbara
    Intlekofer, Andrew M.
    Ahn, Jihae
    Shank, Kaitlyn
    Rapaport, Franck T.
    Patel, Minal A.
    Papalexi, Efthymia
    Shih, Alan H.
    Chiu, April
    Freinkman, Elizaveta
    Akbay, Esra A.
    Steadman, Mya
    Nagaraja, Raj
    Yen, Katharine
    Teruya-Feldstein, Julie
    Wong, Kwok-Kin
    Rampal, Raajit
    Vander Heiden, Matthew G.
    Thompson, Craig B.
    Levine, Ross L.
    JOURNAL OF CLINICAL INVESTIGATION, 2018, 128 (02): : 789 - 804
12345